AGP Executive Report

Obesity Drugs: South Korea’s plan to flag GLP-1 weight-loss medicines as potentially misused has stalled in preliminary review and will face full committee deliberation. Officials and diabetes experts caution against stigmatizing the drugs, while calling for controls on improper prescribing and illegal sales. Urinary Health: More than 335,000 people in Korea received treatment for urinary stones in 2025; men accounted for about two-thirds of cases. Sudden, severe pain in the side that spreads to the abdomen or groin is a common warning sign. Everyday Nutrition: A consumer test found convenience-store gimbap can contain up to 70% of the recommended daily sodium limit. Pairing a roll with cup noodles can push one meal above the daily limit. Health Insurance: Retirees moving from workplace coverage to regional insurance can face a sharply higher premium burden as home ownership is counted alongside income, even when retirement reduces their earnings.

Food Safety: A Korea Consumer Agency test found convenience-store gimbap contains 760–1,393 mg of sodium per roll—up to 70% of the recommended daily limit. Pairing it with cup noodles can push one meal over that limit. Drug Policy: At a National Assembly audit, lawmakers called for a review of drug-price incentives for medicines made with Korean-produced ingredients, including cases where ingredient makers and drug marketers are separate companies. Health Coverage: Retirees moving from workplace to regional health insurance can face premiums taking up to three times the share of their income, partly because home ownership is counted. Wellness Trend: Enzyme baths, using warm fermented rice bran or cypress sawdust, are gaining attention in Korea. Providers promote health benefits, but the reported appeal is mainly heat and relaxation. Everyday Prevention: Only 46.7% of Koreans reportedly use soap after using the restroom, highlighting a basic hygiene gap. Healthy Habits: A Seoul National University Hospital study of 37,059 adults linked a healthy diet combined with regular physical activity to a lower likelihood of hospitalization.

Workplace Safety: A Bucheon factory fire on Oct. 16 injured eight people, including two firefighters who were seriously hurt; one firefighter was taken to hospital in cardiac arrest. Lung Cancer: A study of more than 4.5 million Korean adults found that former smokers who vaped had higher rates of lung cancer and lung-cancer deaths than people who quit without vaping. The findings show an association, not proof that vaping caused the cancers. Prevention: Seoul National University Hospital researchers studying 37,059 adults found that people who combined a high-quality diet with at least 150 minutes of weekly physical activity were less likely to have been hospitalized; diet or activity alone showed no significant difference in the overall analysis. Eye Health: Glaucoma can damage the optic nerve before vision or eye pressure seems abnormal, so regular checks can help catch it early.

End-of-Life Care: South Korea plans recommendations by year-end to clarify decisions on withdrawing life support and improve care for patients afterward. Obesity Treatment: Novo Nordisk has applied for national insurance coverage of Wegovy, intensifying price competition as a domestic rival prepares to enter the market. Health Financing: The national health insurer faces projected losses of 21 trillion won over five years, putting sustainability in focus. Medical Innovation: LigaChem has dosed the first patient in a global trial of its cancer drug for gastric and pancreatic cancers; Korea also approved a treatment for a rare lung-scarring disease. Prevention: Seoul is offering free vascular-age and blood-pressure checks at Cheonggye Plaza. Sports Safety: Runner and influencer Yoo Ji-won, 25, died after collapsing near the finish of a Seoul half-marathon. Officials have not confirmed the cause.

Free Health Checks: Seoul is offering vascular-age and blood-pressure screenings at Cheonggye Plaza. Rare Disease Care: South Korea has approved a new drug for a rare lung-scarring disease. Medical AI: The government plans a health-data bank covering one million people to support medical AI. Supplement Safety: Reports of adverse events linked to health supplements have risen 2.5-fold in five years. Race Safety: A 25-year-old running influencer died after collapsing near the Seoul Race finish; the cause has not been disclosed, and organizers say they will examine the incident. Everyday Prevention: A report says only one in 10 South Koreans wash their hands properly.

Rare Lung Disease: South Korea approved Jascayd, an imported drug for idiopathic pulmonary fibrosis. It works through a different mechanism from existing treatments and received an expedited review. Everyday Prevention: Only 11.4% of people observed in public bathrooms washed their hands with soap for the recommended 30 seconds; 14% did not wash at all, the KDCA reported. Medical AI: Korea plans a health-data bank covering one million people to support medical AI development. Supplement Safety: Reports of adverse events linked to health supplements have risen 2.5-fold in five years, renewing focus on product safety.

Obesity Treatment: Hanmi plans to launch Eppe, a homegrown GLP-1 drug, later this month at wholesale prices roughly half those of Wegovy and Mounjaro; patients’ final costs may differ. Supplement Safety: Reports of adverse events linked to health supplements in Korea have risen 2.5-fold in five years, according to a new report. Running Safety: A 25-year-old runner and social media creator died after collapsing near the finish of Seoul’s half-marathon. The cause of death has not been disclosed. Cancer Drugs: Korea’s Elevar resubmitted its application to the US FDA for a liver-cancer drug combination, after addressing manufacturing issues; the agency’s earlier review raised no new concerns about the treatment’s safety or efficacy. Patient Privacy: Reports say 2,672 Korean drug-trial files were accessible without a login, including 2,208 containing officials’ phone numbers. Health Policy: The government is urging lawmakers to revive a 15-year-old service-industry bill, with healthcare matters governed by separate laws excluded from its scope.

Race Safety: A woman in her 20s died after collapsing near the finish of Sunday’s Seoul half-marathon. The cause is under investigation, and organizers say they will review the incident. Supplement Risks: Reports of adverse reactions to health supplements in Korea reached 18,693 from 2021 through June 2026. Last year’s 5,250 reports were about 2.5 times the 2021 total; 3,591 more came in the first half of this year. Cancer Risk: A study of nearly 200,000 Korean adults under 50 linked blood-test signs of accelerated biological aging with higher risk of early-onset colorectal cancer. The findings point to an association, not proof of cause. Imaging Research: Korean researchers developed an AI system combining two image-analysis methods to reduce grainy ultrasound noise while preserving details that may help clinicians identify lesions. Medication Safety: Korea’s drug agency has listed vision loss as a rare side effect of Wegovy and Mounjaro. Patient Privacy: A report says 2,672 Korean drug-trial files were accessed through ChatGPT without a login; 2,208 reportedly contained officials’ phone numbers.

Medication Safety: South Korea’s drug agency now lists vision loss linked to NAION as a rare possible side effect of Wegovy and Mounjaro. One suspected case has been reported, but a causal link is unproven. Emergency Care: Eight people were injured in a stabbing at an Incheon shopping complex; one woman suffered cardiac arrest and remains unconscious after emergency surgery. Pregnancy & Child Health: A study tracking nearly 2.93 million South Korean children found prenatal opioid exposure was associated with a 28% higher rate of hospital admission. The link was smaller in comparisons between siblings. Suicide Prevention: The government’s new national plan targets a 33% cut in suicides by 2030, with regional authorities to be assessed and offered financial incentives. Cancer Research: Daejeon-based Orum Therapeutics has dosed the first patient in a Phase 1 trial of an experimental treatment for acute myeloid leukemia and other blood cancers. Seasonal Health: Morning temperatures are forecast below 10 C in much of the country, with strong winds and sharp day-to-night changes; take care to stay warm.

Emergency Response: Eight people were injured in a stabbing rampage at an Incheon shopping complex on Tuesday; one woman in her 20s went into cardiac arrest and underwent surgery. The suspect was arrested, and the Justice Ministry said it would review oversight of electronic ankle monitors. Maternal Health: South Korea recorded 27 deaths from direct obstetric complications last year, a nine-year high and nearly 60% more than in 2024, reversing a long decline. Medicine Supply: DHL added six temperature-controlled air corridors linking Asian healthcare hubs, including Seoul’s Incheon Airport, with Europe and North America to transport medicines, vaccines and biologics. Vaccination: WHO warned that nearly 1.7 million babies in the Western Pacific missed a routine vaccine dose in 2025, raising the risk of preventable outbreaks across the region.

Suicide Prevention: South Korea has finalized a national plan targeting a 33% drop in suicides by 2030, with regional governments to be graded on prevention efforts and offered financial incentives. COVID Vaccination: The routine autumn campaign has begun, but 4.84 million doses were secured—10% fewer than last season, when demand exceeded this year’s supply. Obesity Care: Prescriptions for obesity drugs have more than doubled from last year, while Wegovy’s developer is seeking National Health Insurance coverage. Disease Preparedness: A new magnetic strip test detected the tick-borne SFTS virus in 45 minutes without lab equipment; the disease has been reported in South Korea. Separately, health authorities say the risk of plague entering the country is very low. Emergency Care: The government will provide up to 15.4 billion won to fund two hub trauma centers. A woman in her 20s also died after collapsing near the finish of Sunday’s Seoul half-marathon; the cause is under investigation.

Suicide Prevention: South Korea’s new national plan targets a 33% cut in suicides by 2030, to 18.9 deaths per 100,000 people. The government will grade local authorities, reward stronger prevention efforts and expand early detection and treatment. Worker Health: DN Automotive is under police investigation over allegations that it gave Ulsan factory workers lead-removal injections disguised as vitamin shots before health checks. President Lee ordered a thorough probe after inspectors found workplace lead levels had exceeded the legal limit. Obesity Care: Novo Nordisk has applied for national insurance coverage of Wegovy, saying reimbursement could improve access for people with severe obesity and related conditions. Emergency Care: The government plans to fund two regional hub trauma centers, offering up to 15.4 billion won in support.

Child Care: South Korea had 26,064 daycare centers in 2025, down 41% from the 2013 peak as low birth rates shrink enrollment. The government aims to integrate early education and childcare by 2030. Medical Workforce: Applications to regional medical-school tracks jumped 40% for 2027, with new seats for students who commit to practicing locally. Obesity Treatment: Hanmi’s Eppe won approval as South Korea’s first homegrown GLP-1 obesity drug, opening a new option in a market dominated by imports. Patient Safety: A ceiling collapse at a Daegu supermarket injured at least 38 people. Health Data: Reports that stolen Korean patient records were being traded openly online raise fresh concerns about medical privacy.

Medical Training: Applications to regional-student tracks across health-related programs rose 40.3% for 2027 admissions, with a new quota reserving 466 medical-school places for students who commit to practicing locally. Child Care: South Korea had 26,064 daycare centers in 2025, down 41% from the 2013 peak. The government aims to integrate early education and childcare by 2030. Public Safety: A supermarket ceiling collapsed in Daegu, injuring 38 shoppers; nine were taken to hospital as investigators examine possible structural and maintenance failures. Obesity Treatment: Hanmi Pharm’s Eppe, South Korea’s first homegrown GLP-1 obesity drug, has won approval, offering a domestic alternative in a market dominated by imports. Patient Privacy: Reports of stolen patient records being traded online and gynecology examination footage leaked to overseas sites have raised fresh concerns about security at Korean medical facilities.

Public Safety: A supermarket ceiling collapsed in Daegu on Oct. 10, injuring 38 people, mostly lightly. Nine were taken to hospital, and all 66 shoppers escaped; officials are investigating the cause. Patient Privacy: Sensitive records allegedly stolen from South Korean clinics are being offered for sale online, while footage from clinics and treatment rooms has also surfaced on illegal sites, raising fresh concerns about safeguards for patient data. Obesity Care: Korea’s obesity-drug market is expanding, with Hanmi’s Efpe joining Wegovy and Mounjaro after approval of the country’s first homegrown GLP-1 drug. Cost and convenience remain hurdles for wider access. Health Research: A controlled study found people had a smaller short-term rise in blood glucose when eating with a close companion, but researchers say it does not show that social meals lower blood sugar throughout the day.

Public Safety: A ceiling collapse at a Daegu supermarket injured at least 38 people, mostly with minor injuries; 66 shoppers evacuated, and authorities are investigating the cause. Patient Privacy: Stolen records allegedly taken from a South Korean plastic surgery clinic—including names, phone numbers and treatment histories—were offered for sale online, raising fears they could fuel further cybercrime. Obesity Care: Hanmi Pharmaceutical’s homegrown obesity drug has won domestic approval, adding a potential lower-cost option to a market led by Wegovy and Mounjaro. Dementia Research: A study of more than 316,000 Korean adults found that unusually low or high hemoglobin levels were associated with greater dementia risk; researchers say the routine blood test may offer clues, not a diagnosis.